세계의 말초동맥질환 시장보고서(2025년)

Peripheral Artery Disease (PAD) is a condition characterized by the narrowing or blockage of arteries, predominantly affecting the limbs, especially the legs. Atherosclerosis, marked by the buildup of fatty deposits (plaques) within artery walls, is the primary cause, leading to diminished blood flow to the affected areas.

Key products in the peripheral artery disease market encompass peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Specifically, peripheral angioplasty balloons are medical devices engineered to expand narrowed or obstructed peripheral arteries. In the context of peripheral artery disease, these balloons play a crucial role in reopening arteries by inflating to compress plaques, ultimately widening the artery and restoring proper blood flow. Various pharmaceutical interventions involve lipid-lowering drugs, blood pressure-lowering drugs, glucose-regulating drugs, blood clot-preventing drugs, inotropes, thrombolytic agents, and anti-inflammatory agents. These medications are administered through diverse routes, including oral and parenteral, and cater to different end users such as hospitals, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral artery disease market size has grown strongly in recent years. It will grow from $4.31 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives.

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $6.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to a focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, and targeted drug therapies. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), and shift to outpatient settings.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. hospital operations by inflating prices of safety-engineered IV catheters and insertion kits manufactured in Mexico and Costa Rica, resulting in higher supply costs and potential delays in patient vascular access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of peripheral artery diseases is anticipated to drive the growth of the peripheral artery disease market in the future. Peripheral artery disease involves the narrowing or blockage of arteries outside the heart, primarily in the legs, leading to reduced blood flow and potential complications. Treatment for peripheral artery disease aims to alleviate symptoms, improve mobility, and lower the risk of severe complications, thereby enhancing patients' overall well-being. For example, in June 2023, the American Heart Association, a U.S.-based nonprofit organization, estimated that between 7 to 12 million individuals in the United States and approximately 200 million people worldwide are affected by this condition. Therefore, the rising prevalence of peripheral artery diseases is propelling the growth of the peripheral artery disease market.

The significant driver for market growth is the expanding size of the aging population. As the proportion of older individuals in the population steadily rises, there is an associated increase in the likelihood of developing atherosclerosis, a major risk factor for peripheral artery disease. Atherosclerosis involves the narrowing or blockage of arteries due to the accumulation of fatty deposits, leading to reduced blood flow to the limbs. According to the World Health Organization's October 2022 report, the global aging population is expected to substantially increase, with 1 in 6 people worldwide projected to be aged 60 years or older by 2030. This demographic shift is accompanied by a rise in individuals aged 80 years or older, expected to triple between 2020 and 2050. Consequently, the aging population is anticipated to drive demand for peripheral artery disease treatments, contributing to the overall growth of the market.

The peripheral artery disease market is witnessing a significant trend towards technological advancements, with major companies adopting advanced surgical treatments to maintain their market positions. A notable example is Genesis MedTech Group, a Singapore-based medical device company, introducing the Chocolate Touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter is designed for treating patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon, a pioneering catheter in the field, integrates therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It features pillow-such as structures covered with a therapeutic chemical, providing an alternative therapy to standard drug-coated balloon angioplasty. The unique design increases the balloon surface, enabling more effective medication delivery to the vessel wall and eliminating the need for permanent implants.

The growth of the peripheral artery disease market is expected to be propelled by increasing obesity rates. Obesity, characterized by the excess accumulation of body fat with negative health implications, is a significant contributing factor to peripheral artery disease (PAD). PAD involves the narrowing or blockage of blood vessels supplying blood to the legs, resulting in pain and difficulty walking. Notably, as of May 2022, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that over 2 in 5 adults (42.4%) have obesity, with about 1 in 11 adults (9.2%) experiencing severe obesity. This upward trend in obesity rates is driving the demand for peripheral artery disease treatments.

In April 2023, Abbott Laboratories, a prominent US-based medical device company, acquired Cardiovascular Systems Inc. The acquisition, conducted for an undisclosed amount, expands and enriches Abbott's peripheral and coronary artery disease portfolio. Cardiovascular Systems Inc., a US-based medical device company specializing in manufacturing peripheral artery disease products, brings innovative atherectomy systems to further enhance Abbott's offerings in this medical domain.

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of revenues earned by entities by providing peripheral artery disease management services and therapies such as diagnosis, angioplasty, atherectomy, lithoplasty, endovascular, vascular surgery, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral artery disease market also includes sales of guidewires, bare metal, drug-eluting, compression stockings, and exercise equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Artery Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Peripheral Angioplasty Balloons; Peripheral Stents; Peripheral Catheters; Inferior Vena Cava (IVC) Filters; Plaque Modification Devices; Hemodynamic Flow Alteration Devices; Peripheral Accessories
• 2) By Drugs: Lipid-Lowering Drugs; Blood Pressure Lowering Drugs; Glucose Regulating Drugs; Blood Clot Preventing Drugs; Inotropes; Thrombolytics Agents; Anti-Inflammatory Agents
• 3) By Route of Administration: Oral; Parenteral; Other Routes of Administration
• 4) By End Users: Hospitals; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons; Non-Drug-Eluting Balloons; Scoring Balloons; Cutting Balloons
• 2) By Peripheral Stents: Drug-Eluting Stents; Bare Metal Stents; Covered Stents
• 3) By Peripheral Catheters: Sheath Introducers; Guidewires; Diagnostic Catheters; Delivery Catheters
• 4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters; Permanent IVC Filters
• 5) By Plaque Modification Devices: Atherectomy Devices; Laser Atherectomy Devices; Rotational Atherectomy Devices
• 6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices; Flow Restriction Devices
• 7) By Peripheral Accessories: Diagnostic Imaging Accessories; Accessory Kits for Interventional Procedures; Support Devices
• Companies Mentioned: Cardinal Health Inc.; Vascular Solutions Inc.; Bayer AG; Abbott Laboratories; Medtronic plc.; Koninklijke Philips N.V. (Royal Philips); B. Braun Melsungen AG.; Terumo Corporation; Edwards Lifesciences; Becton Dickinson and Company (BD); Boston Scientific Corporation Incorporated; Cook Group Incorporated; Merit Medical Systems Inc.; NuVasive Inc.; Arjo AB; Penumbra Inc.; BIOTRONIK SE and Co. KG; AngioDynamics Inc.; Shockwave Medical Inc.; Cardiovascular Systems Inc.; Endologix LLC.; LeMaitre Vascular Inc.; Silk Road Medical Inc.; WL Gore and Associates Inc.; MicroPort Scientific Corporation; Bard Peripheral Vascular Inc.; Avinger Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peripheral Artery Disease Market Characteristics

3. Peripheral Artery Disease Market Trends And Strategies

4. Peripheral Artery Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Peripheral Artery Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peripheral Artery Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peripheral Artery Disease Market Growth Rate Analysis
• 5.4. Global Peripheral Artery Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peripheral Artery Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peripheral Artery Disease Total Addressable Market (TAM)

6. Peripheral Artery Disease Market Segmentation

• 6.1. Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories
• 6.2. Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid-Lowering Drugs
• Blood Pressure Lowering Drugs
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs
• Inotropes
• Thrombolytics Agents
• Anti-Inflammatory Agents
• 6.3. Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.4. Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End Users
• 6.5. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Angioplasty Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloons
• Non-Drug-Eluting Balloons
• Scoring Balloons
• Cutting Balloons
• 6.6. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Stents
• Bare Metal Stents
• Covered Stents
• 6.7. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sheath Introducers
• Guidewires
• Diagnostic Catheters
• Delivery Catheters
• 6.8. Global Peripheral Artery Disease Market, Sub-Segmentation Of Inferior Vena Cava (IVC) Filters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retrievable IVC Filters
• Permanent IVC Filters
• 6.9. Global Peripheral Artery Disease Market, Sub-Segmentation Of Plaque Modification Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atherectomy Devices
• Laser Atherectomy Devices
• Rotational Atherectomy Devices
• 6.10. Global Peripheral Artery Disease Market, Sub-Segmentation Of Hemodynamic Flow Alteration Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flow Diversion Devices
• Flow Restriction Devices
• 6.11. Global Peripheral Artery Disease Market, Sub-Segmentation Of Peripheral Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging Accessories
• Accessory Kits for Interventional Procedures
• Support Devices

7. Peripheral Artery Disease Market Regional And Country Analysis

• 7.1. Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Artery Disease Market

• 8.1. Asia-Pacific Peripheral Artery Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Artery Disease Market

• 9.1. China Peripheral Artery Disease Market Overview
• 9.2. China Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Artery Disease Market

• 10.1. India Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Artery Disease Market

• 11.1. Japan Peripheral Artery Disease Market Overview
• 11.2. Japan Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Artery Disease Market

• 12.1. Australia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Artery Disease Market

• 13.1. Indonesia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Artery Disease Market

• 14.1. South Korea Peripheral Artery Disease Market Overview
• 14.2. South Korea Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Artery Disease Market

• 15.1. Western Europe Peripheral Artery Disease Market Overview
• 15.2. Western Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Artery Disease Market

• 16.1. UK Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Artery Disease Market

• 17.1. Germany Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Artery Disease Market

• 18.1. France Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Artery Disease Market

• 19.1. Italy Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Artery Disease Market

• 20.1. Spain Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Artery Disease Market

• 21.1. Eastern Europe Peripheral Artery Disease Market Overview
• 21.2. Eastern Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Artery Disease Market

• 22.1. Russia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Artery Disease Market

• 23.1. North America Peripheral Artery Disease Market Overview
• 23.2. North America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Artery Disease Market

• 24.1. USA Peripheral Artery Disease Market Overview
• 24.2. USA Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Artery Disease Market

• 25.1. Canada Peripheral Artery Disease Market Overview
• 25.2. Canada Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Artery Disease Market

• 26.1. South America Peripheral Artery Disease Market Overview
• 26.2. South America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Artery Disease Market

• 27.1. Brazil Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Artery Disease Market

• 28.1. Middle East Peripheral Artery Disease Market Overview
• 28.2. Middle East Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Artery Disease Market

• 29.1. Africa Peripheral Artery Disease Market Overview
• 29.2. Africa Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles

• 30.1. Peripheral Artery Disease Market Competitive Landscape
• 30.2. Peripheral Artery Disease Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Vascular Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Artery Disease Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips N.V. (Royal Philips)
• 31.2. B. Braun Melsungen AG.
• 31.3. Terumo Corporation
• 31.4. Edwards Lifesciences
• 31.5. Becton Dickinson and Company (BD)
• 31.6. Boston Scientific Corporation Incorporated
• 31.7. Cook Group Incorporated
• 31.8. Merit Medical Systems Inc.
• 31.9. NuVasive Inc.
• 31.10. Arjo AB
• 31.11. Penumbra Inc.
• 31.12. BIOTRONIK SE and Co. KG
• 31.13. AngioDynamics Inc.
• 31.14. Shockwave Medical Inc.
• 31.15. Cardiovascular Systems Inc.

32. Global Peripheral Artery Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Artery Disease Market

34. Recent Developments In The Peripheral Artery Disease Market

35. Peripheral Artery Disease Market High Potential Countries, Segments and Strategies

• 35.1 Peripheral Artery Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peripheral Artery Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peripheral Artery Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer